Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyson W Wong

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 13, 2023
The Fatigue Severity Scale in Interstitial Lung Disease: An Energizing EndpointAlyson W Wong, Kerri A Johannson
Thorax|April 30, 2024
Epidemiology of idiopathic pulmonary fibrosis: opportunities and hurdles for population-level studies of rare diseaseDaniel-Costin Marinescu, Alyson W Wong
Archivos De Bronconeumologia|December 2, 2025
Defining Progressive Pulmonary Fibrosis: Implications for Clinical Trials, Guidelines, and Patient CareAlyson W Wong, Christopher J Ryerson
Clinics in Chest Medicine|May 24, 2021
Providing Patient-Centered Care in Interstitial Lung DiseaseAlyson W Wong, Sonye K Danoff
Annals of the American Thoracic Society|April 29, 2022
The Genomic Classifier and Our Quest for Diagnostic Certainty in Interstitial Lung DiseaseAlyson W Wong, Jolene H Fisher
Respiratory Research|January 31, 2020
Progression of fibrosing interstitial lung diseaseAlyson W Wong, Christopher J Ryerson, Sabina A Guler
Annals of the American Thoracic Society|July 2, 2020
Diagnostic Features in Combined Pulmonary Fibrosis and Emphysema: A Systematic ReviewAlyson W Wong, Jiaming Liang, Vincent Cottin, et al.
BMC Pulmonary Medicine|April 21, 2022
A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapiesAlyson W Wong, John Koo, Christopher J Ryerson, et al.
The European Respiratory Journal|October 3, 2020
Patient-reported outcome measures after COVID-19: a prospective cohort studyAlyson W Wong, Aditi S Shah, James C Johnston, et al.
Chest|December 18, 2021
Malignancy Risk Associated With Mycophenolate Mofetil or Azathioprine in Patients With Fibrotic Interstitial Lung DiseaseStacey D Lok, Alyson W Wong, Yet H Khor, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
American Journal of Respiratory and Critical Care Medicine|June 13, 2023
The Fatigue Severity Scale in Interstitial Lung Disease: An Energizing EndpointAlyson W Wong, Kerri A Johannson
Thorax|April 30, 2024
Epidemiology of idiopathic pulmonary fibrosis: opportunities and hurdles for population-level studies of rare diseaseDaniel-Costin Marinescu, Alyson W Wong
Archivos De Bronconeumologia|December 2, 2025
Defining Progressive Pulmonary Fibrosis: Implications for Clinical Trials, Guidelines, and Patient CareAlyson W Wong, Christopher J Ryerson
Clinics in Chest Medicine|May 24, 2021
Providing Patient-Centered Care in Interstitial Lung DiseaseAlyson W Wong, Sonye K Danoff
Annals of the American Thoracic Society|April 29, 2022
The Genomic Classifier and Our Quest for Diagnostic Certainty in Interstitial Lung DiseaseAlyson W Wong, Jolene H Fisher
Respiratory Research|January 31, 2020
Progression of fibrosing interstitial lung diseaseAlyson W Wong, Christopher J Ryerson, Sabina A Guler
Annals of the American Thoracic Society|July 2, 2020
Diagnostic Features in Combined Pulmonary Fibrosis and Emphysema: A Systematic ReviewAlyson W Wong, Jiaming Liang, Vincent Cottin, et al.
BMC Pulmonary Medicine|April 21, 2022
A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapiesAlyson W Wong, John Koo, Christopher J Ryerson, et al.
The European Respiratory Journal|October 3, 2020
Patient-reported outcome measures after COVID-19: a prospective cohort studyAlyson W Wong, Aditi S Shah, James C Johnston, et al.
Chest|December 18, 2021
Malignancy Risk Associated With Mycophenolate Mofetil or Azathioprine in Patients With Fibrotic Interstitial Lung DiseaseStacey D Lok, Alyson W Wong, Yet H Khor, et al.
Pageof 6